Fig. 3From: PKP/PVP combine chemotherapy in the treatment of multiple myeloma patients with vertebral pathological fractures: minimum 3-year follow-up of 108 casesa Comparison of OS in patients within ISS stages I, II, and III, among which, the OS in patients within ISS stages I and II was significantly higher than that within ISS stage III (P < 0.001), and there was no significant difference in the OS in patients within ISS stages I and II (P > 0.05). b No significant difference in the OS in patients in the surgical and non-surgical groups (P > 0.05)Back to article page